AGF Management’s Globus Medical GMED Stock Holding History

AGF Management’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-6,422	Closed	-$344K	–	714
2024 Q1	$344K	Buy	+6,422	New	+$345K	﹤0.01%	666

Other funds holding GMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BAM

Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

AGF Management's GMED Position: Q2 2024 in Review

AGF Management sold out of Globus Medical (GMED) in Q2 2024, closing a stake of 6,422 shares — an estimated $344K sold.

AGF Management first reported a position in GMED in Q1 2024 and held it in 1 quarter. The position peaked at $344K in Q1 2024. 450 funds tracked by Wall St. Rank hold GMED as of Q2 2024.

AGF Management reported no remaining Globus Medical position as of Q2 2024 after selling out during the quarter.
AGF Management sold 6,422 Globus Medical shares in Q2 2024, an estimated $344K.
AGF Management first reported a position in Globus Medical in Q1 2024 and held it in 1 quarter.
AGF Management's Globus Medical position peaked at $344K in Q1 2024.
450 funds tracked by Wall St. Rank held Globus Medical as of Q2 2024.

Based on AGF Management's 13F filing for Q2 2024, filed 7 Aug 2024.